Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, announced today that the United States Patent and Trademark Office (USPTO) has issued U.S. Patent No


Read the whole story here:
USPTO issues patent for Rosetta Genomics’ human microRNA miR-193b (News-Medical-Net)